{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:29:36Z","timestamp":1789784976453,"version":"4.0.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People&apos;s Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32371273"],"award-info":[{"award-number":["32371273"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32071191"],"award-info":[{"award-number":["32071191"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["XDB37020302"],"award-info":[{"award-number":["XDB37020302"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ijbiomac.2024.131721","type":"journal-article","created":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T22:51:26Z","timestamp":1713653486000},"page":"131721","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"P2","title":["Structural basis for the recognition of IFNAR1 by the humanized therapeutic monoclonal antibody QX006N for the treatment of systemic lupus erythematosus"],"prefix":"10.1016","volume":"268","author":[{"given":"Xiaorong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiliang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ijbiomac.2024.131721_bb0005","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nrd2422","article-title":"Interferons at age 50: past, current and future impact on biomedicine","volume":"6","author":"Borden","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.131721_bb0010","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/ni.2686","article-title":"Ifn-\u03b2-specific signaling via a unique ifnar1 interaction","volume":"14","author":"Kaur","year":"2013","journal-title":"Nat. Immunol."},{"issue":"39","key":"10.1016\/j.ijbiomac.2024.131721_bb0015","doi-asserted-by":"crossref","first-page":"12498","DOI":"10.1021\/bi049111r","article-title":"Identification of residues of the ifnar1 chain of the type i human interferon receptor critical for ligand binding and biological activity","volume":"43","author":"Cajean-Feroldi","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2024.131721_bb0020","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1600-065X.2008.00698.x","article-title":"Inborn errors of interferon (ifn)-mediated immunity in humans: insights into the respective roles of ifn-alpha\/beta, ifn-gamma, and ifn-lambda in host defense","volume":"226","author":"Zhang","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ijbiomac.2024.131721_bb0025","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2004.00204.x","article-title":"Interferons, interferon-like cytokines, and their receptors","volume":"202","author":"Pestka","year":"2004","journal-title":"Immunol. Rev."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.131721_bb0030","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.immuni.2012.03.013","article-title":"The jak-stat pathway at twenty","volume":"36","author":"Stark","year":"2012","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131721_bb0035","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type i interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.131721_bb0040","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41577-021-00633-9","article-title":"The type i interferonopathies: 10 years on","volume":"22","author":"Crow","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.131721_bb0045","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-i- and type-ii-interferon-mediated signalling","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ijbiomac.2024.131721_bb0050","first-page":"71","article-title":"The receptor of the type i interferon family","volume":"316","author":"Uze","year":"2007","journal-title":"Curr.Top.Microbiol.Immunol."},{"issue":"15","key":"10.1016\/j.ijbiomac.2024.131721_bb0055","doi-asserted-by":"crossref","first-page":"11602","DOI":"10.1074\/jbc.M610115200","article-title":"An interferon alpha2 mutant optimized by phage display for ifnar1 binding confers specifically enhanced antitumor activities","volume":"282","author":"Kalie","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.131721_bb0060","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.cell.2011.06.048","article-title":"Structural linkage between ligand discrimination and receptor activation by type i interferons","volume":"146","author":"Thomas","year":"2011","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.131721_bb0065","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1128\/MCB.26.5.1888-1897.2006","article-title":"Inquiring into the differential action of interferons (ifns): an ifn-alpha2 mutant with enhanced affinity to ifnar1 is functionally similar to ifn-beta","volume":"26","author":"Jaitin","year":"2006","journal-title":"Mol. Cell. Biol."},{"issue":"16","key":"10.1016\/j.ijbiomac.2024.131721_bb0070","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1016\/j.jmb.2017.06.011","article-title":"Dynamic modulation of binding affinity as a mechanism for regulating interferon signaling","volume":"429","author":"Li","year":"2017","journal-title":"J. Mol. Biol."},{"issue":"29","key":"10.1016\/j.ijbiomac.2024.131721_bb0075","doi-asserted-by":"crossref","first-page":"18747","DOI":"10.1016\/S0021-9258(17)32231-7","article-title":"Knockout and reconstitution of a functional human type i interferon receptor complex","volume":"269","author":"Cleary","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"20","key":"10.1016\/j.ijbiomac.2024.131721_bb0080","doi-asserted-by":"crossref","first-page":"9602","DOI":"10.1073\/pnas.91.20.9602","article-title":"Role of interferon alpha\/beta receptor chain 1 in the structure and transmembrane signaling of the interferon alpha\/beta receptor complex","volume":"91","author":"Constantinescu","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5775","key":"10.1016\/j.ijbiomac.2024.131721_bb0085","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1126\/science.1125676","article-title":"Type 1 interferons and the virus-host relationship: a lesson in detente","volume":"312","author":"Garcia-Sastre","year":"2006","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131721_bb0090","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cytogfr.2003.10.001","article-title":"The class ii cytokine receptor (crf2) family: overview and patterns of receptor-ligand interactions","volume":"15","author":"Langer","year":"2004","journal-title":"Cytokine Growth Factor Rev."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.131721_bb0095","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jmb.2006.11.053","article-title":"Differential receptor subunit affinities of type i interferons govern differential signal activation","volume":"366","author":"Jaks","year":"2007","journal-title":"J. Mol. Biol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.131721_bb0100","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0092-8674(90)90738-Z","article-title":"Genetic transfer of a functional human interferon alpha receptor into mouse cells: cloning and expression of its cdna","volume":"60","author":"Uz\u00e9","year":"1990","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131721_bb0105","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1089\/jir.1995.15.55","article-title":"Human type i interferon receptor, ifnar, is a heavily glycosylated 120-130 kd membrane protein","volume":"15","author":"Ling","year":"1995","journal-title":"J. Interf. Cytokine Res."},{"issue":"28","key":"10.1016\/j.ijbiomac.2024.131721_bb0110","doi-asserted-by":"crossref","first-page":"20053","DOI":"10.1074\/jbc.R700006200","article-title":"Type i interferon receptors: biochemistry and biological functions","volume":"282","author":"de Weerd","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.131721_bb0115","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0092-8674(94)90154-6","article-title":"The human interferon alpha\/beta receptor: characterization and molecular cloning","volume":"77","author":"Novick","year":"1994","journal-title":"Cell"},{"issue":"23","key":"10.1016\/j.ijbiomac.2024.131721_bb0120","doi-asserted-by":"crossref","first-page":"13448","DOI":"10.1074\/jbc.271.23.13448","article-title":"Differential responsiveness of a splice variant of the human type i interferon receptor to interferons","volume":"271","author":"Cook","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"2\u20133","key":"10.1016\/j.ijbiomac.2024.131721_bb0125","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0014-5793(97)00129-4","article-title":"Contributions of cloned type i interferon receptor subunits to differential ligand binding","volume":"404","author":"Cutrone","year":"1997","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.131721_bb0130","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1080\/19420862.2015.1007810","article-title":"Molecular basis for antagonistic activity of anifrolumab, an anti-interferon-alpha receptor 1 antibody","volume":"7","author":"Peng","year":"2015","journal-title":"Mabs"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.131721_bb0135","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jmb.2008.01.017","article-title":"Ligand binding induces a conformational change in ifnar1 that is propagated to its membrane-proximal domain","volume":"377","author":"Strunk","year":"2008","journal-title":"J. Mol. Biol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.131721_bb0140","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.4049\/jimmunol.160.4.1782","article-title":"Structure-function study of the extracellular domain of the human ifn-alpha receptor (hifnar1) using blocking monoclonal antibodies: the role of domains 1 and 2","volume":"160","author":"Lu","year":"1998","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131721_bb0145","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM197907053010102","article-title":"Immune interferon in the circulation of patients with autoimmune disease","volume":"301","author":"Hooks","year":"1979","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.131721_bb0150","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/s41590-019-0466-2","article-title":"Interferon target-gene expression and epigenomic signatures in health and disease","volume":"20","author":"Barrat","year":"2019","journal-title":"Nat. Immunol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.131721_bb0155","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1136\/ard.2011.150326","article-title":"Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type i interferon pathway","volume":"70","author":"Higgs","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.131721_bb0160","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3390\/cells8090963","article-title":"Signaling pathways of type i and type iii interferons and targeted therapies in systemic lupus erythematosus","volume":"8","author":"Chyuan","year":"2019","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.131721_bb0165","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41584-021-00606-1","article-title":"Interferon lambda in inflammation and autoimmune rheumatic diseases","volume":"17","author":"Goel","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.131721_bb0170","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/art.39962","article-title":"Anifrolumab, an anti-interferon-alpha receptor monoclonal antibody, in moderate-to-severe systemic lupus erythematosus","volume":"69","author":"Furie","year":"2017","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.131721_bb0175","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/acr2.11414","article-title":"Interferon inhibition for lupus with anifrolumab: critical appraisal of the evidence leading to fda approval","volume":"4","author":"Loncharich","year":"2022","journal-title":"Acr Open Rheumatol"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.131721_bb0180","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/art.42392","article-title":"A randomized, placebo-controlled phase iii extension trial of the long-term safety and tolerability of anifrolumab in active systemic lupus erythematosus","volume":"75","author":"Kalunian","year":"2023","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ijbiomac.2024.131721_bb0185","series-title":"Anti-human Interferon Alpha Receptor 1 Monoclonal Antibody and Its Application","author":"Jiwan","year":"2021"},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.131721_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232311","article-title":"Rapid and robust antibody fab fragment crystallization utilizing edge-to-edge beta-sheet packing","volume":"15","author":"Lieu","year":"2020","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.131721_bb0195","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s41365-018-0398-9","article-title":"Upgrade of macromolecular crystallography beamline bl17u1 at ssrf","volume":"29","author":"Wang","year":"2018","journal-title":"Nucl. Sci. Tech."},{"key":"10.1016\/j.ijbiomac.2024.131721_bb0200","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","article-title":"Processing of x-ray diffraction data collected in oscillation mode","volume":"276","author":"Otwinowski","year":"1997","journal-title":"Methods Enzymol."},{"issue":"Pt 1","key":"10.1016\/j.ijbiomac.2024.131721_bb0205","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1107\/S0907444906045975","article-title":"Solving structures of protein complexes by molecular replacement with phaser","volume":"63","author":"Mccoy","year":"2007","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"issue":"Pt 12 Pt 1","key":"10.1016\/j.ijbiomac.2024.131721_bb0210","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"issue":"Pt 2","key":"10.1016\/j.ijbiomac.2024.131721_bb0215","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"Phenix: a comprehensive python-based system for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"issue":"Pt 1","key":"10.1016\/j.ijbiomac.2024.131721_bb0220","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"Molprobity: all-atom structure validation for macromolecular crystallography","volume":"66","author":"Chen","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.131721_bb0225","first-page":"121","article-title":"Cxcl10\/ip-10 in infectious diseases pathogenesis and potential therapeutic implications","volume":"22","author":"Liu","year":"2011","journal-title":"Cytokine Growth Factor Rev."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.131721_bb0230","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nri844","article-title":"Baff: a fundamental survival factor for b cells","volume":"2","author":"Mackay","year":"2002","journal-title":"Nat. Rev. Immunol."},{"issue":"2 Suppl 2","key":"10.1016\/j.ijbiomac.2024.131721_bb0235","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.jaci.2009.09.046","article-title":"Structure and function of immunoglobulins","volume":"125","author":"Schroeder","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ijbiomac.2024.131721_bb0240","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/978-1-4939-2999-3_2","article-title":"The structure of natural and recombinant antibodies","volume":"1348","author":"Ma","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2024.131721_bb0245","series-title":"Immunobiology: The Immune System in Health and Disease","author":"Janeway","year":"2001"},{"key":"10.1016\/j.ijbiomac.2024.131721_bb0250","series-title":"M. E, Janeway\u2019s immunobiology","author":"Duan","year":"2016"},{"key":"10.1016\/j.ijbiomac.2024.131721_bb0255","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1146\/annurev.bi.48.070179.004525","article-title":"Three-dimensional structure of immunoglobulins","volume":"48","author":"Amzel","year":"1979","journal-title":"Annu. Rev. Biochem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131721_bb0260","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41420-021-00550-9","article-title":"Current insights into the expression and functions of tumor-derived immunoglobulins","volume":"7","author":"Zhao","year":"2021","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.131721_bb0265","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jmb.2005.05.008","article-title":"Functional cartography of the ectodomain of the type i interferon receptor subunit ifnar1","volume":"350","author":"Lamken","year":"2005","journal-title":"J. Mol. Biol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.131721_bb0270","first-page":"560","article-title":"Localization of a receptor nonapeptide with a possible role in the binding of the type i interferons","volume":"11","author":"Eid","year":"2000","journal-title":"Eur. Cytokine Netw."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.131721_bb0275","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3109\/10409238409117796","article-title":"Structural and functional aspects of domain motions in proteins","volume":"15","author":"Bennett","year":"1984","journal-title":"CRC Crit. Rev. Biochem."},{"key":"10.1016\/j.ijbiomac.2024.131721_bb0280","first-page":"201","article-title":"Predicting disordered regions from amino acid sequence: common themes despite differing structural characterization","volume":"9","author":"Garner","year":"1998","journal-title":"Genome Inform Ser Workshop Genome Inform."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.131721_bb0285","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/pro.2864","article-title":"Resolving the ambiguity: making sense of intrinsic disorder when pdb structures disagree","volume":"25","author":"Deforte","year":"2016","journal-title":"Protein Sci."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.131721_bb0290","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jmb.2007.12.005","article-title":"The em structure of a type i interferon-receptor complex reveals a novel mechanism for cytokine signaling","volume":"377","author":"Li","year":"2008","journal-title":"J. Mol. Biol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.131721_bb0295","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/ni.2667","article-title":"Structural basis of a unique interferon-beta signaling axis mediated via the receptor ifnar1","volume":"14","author":"de Weerd","year":"2013","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.131721_bb0300","doi-asserted-by":"crossref","first-page":"707","DOI":"10.4049\/jimmunol.150.3.707","article-title":"A monoclonal antibody to recombinant human ifn-alpha receptor inhibits biologic activity of several species of human ifn-alpha, ifn-beta, and ifn-omega. Detection of heterogeneity of the cellular type i ifn receptor","volume":"150","author":"Benoit","year":"1993","journal-title":"J. Immunol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024025261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024025261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T10:05:22Z","timestamp":1778666722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813024025261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":60,"alternative-id":["S0141813024025261"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.131721","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural basis for the recognition of IFNAR1 by the humanized therapeutic monoclonal antibody QX006N for the treatment of systemic lupus erythematosus","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.131721","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"131721"}}